599 results on '"Fowler, Stephen J."'
Search Results
2. Exhaled volatile organic compounds and respiratory disease: Recent progress and future outlook
3. Clinical Characteristics and Impact of Inducible Laryngeal Obstruction in the UK National Registry
4. The role of inflammation in anxiety and depression in the European U-BIOPRED asthma cohorts
5. Stratification of asthma by lipidomic profiling of induced sputum supernatant
6. Domiciliary Fractional Exhaled Nitric Oxide and Spirometry in Monitoring Asthma Control and Exacerbations
7. A Randomized Trial of a Composite T2-Biomarker Strategy Adjusting Corticosteroid Treatment in Severe Asthma: A Post Hoc Analysis by Sex
8. Molecular phenotyping approaches for the detection and monitoring of carbapenem-resistant Enterobacteriaceae by mass spectrometry
9. A systematic approach to assessing complex breathlessness
10. Composition and diversity analysis of the lung microbiome in patients with suspected ventilator-associated pneumonia
11. Therapy outcome measure for inducible laryngeal obstruction and chronic cough: development and testing of reliability and validity.
12. Protocol for a scoping review to map health outcomes in individuals with inducible laryngeal obstruction.
13. Diagnosing Asthma with and without Aerosol-Generating Procedures
14. Serum Inhaled Corticosteroid Detection for Monitoring Adherence in Severe Asthma
15. Composite type-2 biomarker strategy versus a symptom–risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial
16. Volatile organic compounds associated with diagnosis and disease characteristics in asthma – A systematic review
17. Volatilomes of human infection
18. Breath and plasma metabolomics to assess inflammation in acute stroke
19. IL-17–high asthma with features of a psoriasis immunophenotype
20. Asthma Diagnosis: The Changing Face of Guidelines
21. Allergen challenge increases capsaicin-evoked cough responses in patients with allergic asthma
22. Stratification of asthma phenotypes by airway proteomic signatures
23. Identification and prospective stability of electronic nose (eNose)–derived inflammatory phenotypes in patients with severe asthma
24. Exhaled breath testing – A tool for the clinician and researcher
25. Sensitivity and Specificity of the 2022 European Respiratory Society (ERS) Guidelines for the Diagnosis of Asthma in Adults
26. Serum inhaled corticosteroid levels in patients with severe asthma.
27. Changes in lung epithelial cell volatile metabolite profile induced by pro-fibrotic stimulation with TGF-β1
28. Multidisciplinary management of inducible laryngeal obstruction and breathing pattern disorder
29. Low levels of endogenous anabolic androgenic steroids in females with severe asthma taking corticosteroids
30. Changes in exhaled volatile organic compounds following indirect bronchial challenge in suspected asthma
31. Aspergillus sensitisation detection using point-of-care lateral flow assay in moderate to severe asthma
32. Validation of subscales of the Severe Asthma Questionnaire (SAQ) using exploratory factor analysis (EFA)
33. Asthma Innovations from the First International Collaborative Asthma Network (ICAN) Forum
34. Oropharyngeal Microbiota Clusters in Children with Asthma/Wheeze Associate with Allergy, Blood Transcriptomic Immune Pathways and Exacerbations Risk
35. Chewing the fat: How lipidomics is changing our understanding of human health and disease in 2022
36. Influence of bacterial and alveolar cell co-culture on microbial VOC production using HS-GC/MS
37. Clinical biomarkers and noninvasive assessment of severe asthma
38. Contributors
39. Capturing and Storing Exhaled Breath for Offline Analysis
40. Breathomics in the setting of asthma and chronic obstructive pulmonary disease
41. Definitions of non-response and response to biological therapy for severe asthma: a systematic review
42. Volatile metabolites differentiate air–liquid interface cultures after infection with Staphylococcus aureus
43. Exhaled breath analysis: a review of ‘breath-taking’ methods for off-line analysis
44. Objective Cough Frequency, Airway Inflammation, and Disease Control in Asthma
45. Oropharyngeal Microbiota Clusters in Children with Asthma or Wheeze Associate with Allergy, Blood Transcriptomic Immune Pathways, and Exacerbation Risk.
46. Detecting laryngopharyngeal reflux in patients with upper airways symptoms: Symptoms, signs or salivary pepsin?
47. Asthma and Wheeze Severity and the Oropharyngeal Microbiota in Children and Adolescents
48. Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA)
49. Metabolic phenotyping of acquired ampicillin resistance using microbial volatiles from Escherichia coli cultures
50. Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.